Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Cell growth-inhibiting gene 8 (Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein, isoform CRA_a) (cDNA, FLJ92261, highly similar to Homo sapiens inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA)

 Q53T66_HUMAN            Unreviewed;       134 AA.
Q53T66;
24-MAY-2005, integrated into UniProtKB/TrEMBL.
24-MAY-2005, sequence version 1.
12-SEP-2018, entry version 121.
SubName: Full=Cell growth-inhibiting gene 8 {ECO:0000313|EMBL:AAV35470.1};
SubName: Full=Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein, isoform CRA_a {ECO:0000313|EMBL:EAX01018.1};
SubName: Full=cDNA, FLJ92261, highly similar to Homo sapiens inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA {ECO:0000313|EMBL:BAG34927.1};
Name=ID2 {ECO:0000313|EMBL:AAY14810.1};
Synonyms=GIG8 {ECO:0000313|EMBL:AAV35470.1};
ORFNames=hCG_1784377 {ECO:0000313|EMBL:EAX01018.1};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606 {ECO:0000313|EMBL:AAY14810.1};
[1] {ECO:0000313|EMBL:AAY14810.1}
NUCLEOTIDE SEQUENCE.
Du F., Doebber A., Cordum H.;
"The sequence of Homo sapiens BAC clone RP11-434B12.";
Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
[2] {ECO:0000313|EMBL:AAY14810.1}
NUCLEOTIDE SEQUENCE.
Waterston R.H.;
Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
[3] {ECO:0000313|EMBL:EAX01018.1}
NUCLEOTIDE SEQUENCE.
PubMed=11181995; DOI=10.1126/science.1058040;
Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
"The sequence of the human genome.";
Science 291:1304-1351(2001).
[4] {ECO:0000313|EMBL:AAY14810.1}
NUCLEOTIDE SEQUENCE.
Waterston R.;
Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
[5] {ECO:0000313|EMBL:AAV35470.1}
NUCLEOTIDE SEQUENCE.
Kim J.W.;
"Identification of human cell growth-inhibiting gene.";
Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
[6] {ECO:0000313|EMBL:AAY14810.1}
NUCLEOTIDE SEQUENCE.
Wilson R.K.;
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
[7] {ECO:0000313|EMBL:EAX01018.1}
NUCLEOTIDE SEQUENCE.
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[8] {ECO:0000313|EMBL:BAG34927.1}
NUCLEOTIDE SEQUENCE.
TISSUE=Thymus {ECO:0000313|EMBL:BAG34927.1};
Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
Isogai T.;
"NEDO functional analysis of protein and research application
project.";
Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AY634687; AAV35470.1; -; mRNA.
EMBL; AC011747; AAY14810.1; -; Genomic_DNA.
EMBL; AK311988; BAG34927.1; -; mRNA.
EMBL; CH471053; EAX01018.1; -; Genomic_DNA.
EMBL; CH471053; EAX01019.1; -; Genomic_DNA.
RefSeq; NP_002157.2; NM_002166.4.
UniGene; Hs.180919; -.
UniGene; Hs.726053; -.
SMR; Q53T66; -.
MaxQB; Q53T66; -.
DNASU; 3398; -.
GeneID; 3398; -.
KEGG; hsa:3398; -.
UCSC; uc002qza.4; human.
CTD; 3398; -.
EuPathDB; HostDB:ENSG00000115738.9; -.
PharmGKB; PA29609; -.
eggNOG; ENOG410IVXR; Eukaryota.
eggNOG; ENOG4111PGK; LUCA.
HOVERGEN; HBG009009; -.
KO; K17693; -.
OMA; FPSEFMS; -.
OrthoDB; EOG091G0VHR; -.
GenomeRNAi; 3398; -.
Bgee; ENSG00000115738; Expressed in 227 organ(s), highest expression level in adrenal gland.
ExpressionAtlas; Q53T66; baseline and differential.
GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
GO; GO:0005634; C:nucleus; IEA:Ensembl.
GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
GO; GO:0060612; P:adipose tissue development; IEA:Ensembl.
GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
GO; GO:0003166; P:bundle of His development; IEA:Ensembl.
GO; GO:0048469; P:cell maturation; IEA:Ensembl.
GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.
GO; GO:0071285; P:cellular response to lithium ion; IEA:Ensembl.
GO; GO:0090398; P:cellular senescence; IEA:Ensembl.
GO; GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl.
GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
GO; GO:0061031; P:endodermal digestive tract morphogenesis; IEA:Ensembl.
GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IEA:Ensembl.
GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.
GO; GO:0061030; P:epithelial cell differentiation involved in mammary gland alveolus development; IEA:Ensembl.
GO; GO:0045475; P:locomotor rhythm; IEA:Ensembl.
GO; GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl.
GO; GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl.
GO; GO:0001656; P:metanephros development; IEA:Ensembl.
GO; GO:0001779; P:natural killer cell differentiation; IEA:Ensembl.
GO; GO:0045578; P:negative regulation of B cell differentiation; IEA:Ensembl.
GO; GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl.
GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl.
GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
GO; GO:0048541; P:Peyer's patch development; IEA:Ensembl.
GO; GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl.
GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
GO; GO:0071158; P:positive regulation of cell cycle arrest; IEA:Ensembl.
GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl.
GO; GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl.
GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.
GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
GO; GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl.
GO; GO:0001966; P:thigmotaxis; IEA:Ensembl.
CDD; cd00083; HLH; 1.
Gene3D; 4.10.280.10; -; 1.
InterPro; IPR011598; bHLH_dom.
InterPro; IPR026052; DNA-bd_prot-inh.
InterPro; IPR036638; HLH_DNA-bd_sf.
PANTHER; PTHR11723; PTHR11723; 1.
Pfam; PF00010; HLH; 1.
SMART; SM00353; HLH; 1.
SUPFAM; SSF47459; SSF47459; 1.
PROSITE; PS50888; BHLH; 1.
2: Evidence at transcript level;
DOMAIN 23 75 BHLH. {ECO:0000259|PROSITE:PS50888}.
SEQUENCE 134 AA; 14917 MW; A0D98B96396EB11E CRC64;
MKAFSPVRSV RKNSLSDHSL GISRSKTPVD DPMSLLYNMN DCYSKLKELV PSIPQNKKVS
KMEILQHVID YILDLQIALD SHPTIVSLHH QRPGQNQASR TPLTTLNTDI SILSLQASEF
PSELMSNDSK ALCG


Related products :

Catalog number Product name Quantity
ID3 ID1 Gene inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
ID4 ID2 Gene inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
IDDM11 ID4 Gene inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
IDDM10 ID3 Gene inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
201-20-2692 ID1{inhibitor of DNA binding 1, dominant negative helix-loop-helix protein}rabbit.pAb 0.2ml
201-20-2693 ID3{inhibitor of DNA binding 3, dominant negative helix-loop-helix protein}rabbit.pAb 0.2ml
GWB-E28F8D Anti- ID3 (inhibitor of DNA binding 3. dominant negative helix-loop-helix protein) Antibody
GS-1043a inhibitor of DNA binding 3, dominant negative helix-loop-helix protein primary antibody, Host: Rabbit 200ul
GS-1042a inhibitor of DNA binding 1, dominant negative helix-loop-helix protein primary antibody, Host: Rabbit 200ul
CSB-EL010970PI Pig inhibitor of DNA binding 4, dominant negative helix-loop-helix protein (ID4) ELISA kit, Species Pig, Sample Type serum, plasma 96T
CSB-EL010969DO Dog inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3) ELISA kit, Species Dog, Sample Type serum, plasma 96T
CSB-EL010967PI Pig inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2) ELISA kit, Species Pig, Sample Type serum, plasma 96T
CSB-EL010969RA Rat inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL010967RA Rat inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL010966RA Rat inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1) ELISA kit, Species Rat, Sample Type serum, plasma 96T
20-372-60247 inhibitor of DNA binding 2. dominant negative helix-loop-helix protein (ID2) - Mouse monoclonal anti-human ID2 antibody; Inhibitor of DNA binding 2 Monoclonal 0.1 mg
CSB-EL010967HU Human inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010969HU Human inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010970MO Mouse inhibitor of DNA binding 4, dominant negative helix-loop-helix protein (ID4) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL010969BO Bovine inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3) ELISA kit, Species Bovine, Sample Type serum, plasma 96T
CSB-EL010966HU Human inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010970HU Human inhibitor of DNA binding 4, dominant negative helix-loop-helix protein (ID4) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010969MO Mouse inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL010967MO Mouse inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL010966MO Mouse inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1) ELISA kit, Species Mouse, Sample Type serum, plasma 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur